COMMUNIQUÉS West-GlobeNewswire

Two new Board of Director appointments to liquid biopsy company Clinical Genomics
16/10/2018
BRIDGEWATER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer testing solutions and liquid biopsy testing, today announced two appointments to the company’s Board of Directors: [...]
Breathtec to Complete Share Consolidation
16/10/2018
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “ Company ”) is pleased to announce that further to its news release [...]
CRUZANI to Acquire Vitamin Infused Water Beverage Company as First Step to Entering New Infused Products Market
16/10/2018
ATLANTA, Oct. 16, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI), a business development company focused on creating and acquiring global franchise concepts, along with peripheral food-related businesses, is [...]
Radient Technologies and Grupo Natac announce JV to form Natac Solutions
16/10/2018
EDMONTON, Alberta and MADRID, Spain, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Company”) (TSX Venture: RTI), to support its ongoing health and wellness activities, is pleased to [...]
Athenex to Present Positive Data of Oraxol Clinical Trial in Breast Cancer at the ESMO 2018 Congress
16/10/2018
BUFFALO, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation
16/10/2018
External manufacturing agreement reached to enable production of clinical trial materials for SB204 and the acne indication, with the potential to include additional product candidates Extension of capacity complements [...]
SetPoint Medical Completes Enrollment in U.S. Pilot Study Evaluating Bioelectronic Device for Treatment of Rheumatoid Arthritis
16/10/2018
Proprietary Device Delivers Doses of Electricity to Activate Systemic Anti-inflammatory Response Data Readout Expected in Q1 2019 VALENCIA, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage [...]
C-RAD Web Presentation Interim Report Q3 2018
16/10/2018
Presentation of the report for the first three quarters of the fiscal year 2018: Date: Friday October 26, 2018 / kl. 13:00 CEST Venue: Online Presentation Topic: C-RAD Interim Report Q3 2018 Procedure: Please register [...]
Matinas BioPharma to Present at the 8th Annual Partnership Opportunities in Drug Delivery Conference
16/10/2018
BEDMINSTER, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, announced today that Raphael Mannino, Ph.D., Chief Scientific Officer [...]
Selecta Biosciences to Present New Five Monthly Dose Phase 2 Data for SEL-212 in Chronic, Severe Gout at Upcoming 2018 ACR Annual Meeting
16/10/2018
Data continue to suggest sustained serum uric acid (sUA) level reductions and low number of flares over five months of treatment Results correlated with low or no anti-drug antibodies (ADAs) against the pegsiticase [...]
Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors
16/10/2018
NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Samumed to Present Data from Phase 2b Trial of SM04690 for Treatment of Knee Osteoarthritis at 2018 American College of Rheumatology (ACR) Annual Meeting
16/10/2018
Top-line Results to be Released as a Late-Breaking Presentation SAN DIEGO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that data will be presented from a phase 2b trial of its small molecule Wnt [...]
Inspire Medical Systems, Inc. to Report Third Quarter 2018 Financial Results November 6, 2018
16/10/2018
MINNEAPOLIS, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (“Inspire”) (NYSE: INSP), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Progressive Care Inc. Announces 40% Year-Over-Year Increase in Prescriptions Filled and Continued Strong Revenues in September 2018
16/10/2018
MIAMI, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of [...]
Intra-Cellular Therapies Appoints Mark Neumann as Executive Vice President, Chief Commercial Officer
16/10/2018
NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Tabula Rasa HealthCare President Orsula V. Knowlton Receives Mid-Atlantic Women’s Leadership Award
16/10/2018
MOORESTOWN, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ: TRHC), President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA received the CEO Report “Mid- [...]
VBI Vaccines Completes Vaccination in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine
16/10/2018
Vaccination complete in 1,537 subjects in PROTECT Phase 3 study No vaccine-related adverse events have been observed to-date Top-line data expected mid-2019 CAMBRIDGE, Mass., Oct. 16, 2018 (GLOBE NEWSWIRE) -- VBI [...]
Incysus Therapeutics to Present at the 2018 Bio Investor Forum
16/10/2018
NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, [...]
Principia Achieves $10 Million in Additional Milestones Related to Development of PRN2246/SAR442168
16/10/2018
-- Additional milestones achieved under the Sanofi collaboration which is focused on treating diseases of the central nervous system -- SOUTH SAN FRANCISCO, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma [...]

Pages